Who Exports Reagent from India — 93 Suppliers Behind a $13.1M Market
India's reagent export market is supplied by 93 active exporters who collectively shipped $13.1M across 5,370 shipments. ADVY CHEMICAL PRIVATE LIMITED leads with a 52.7% market share, followed by ARKRAY HEALTHCARE PRIVATE LIMITED and BEACON DIAGNOSTICS PVT LTD. The top 5 suppliers together control 86.7% of total export value, reflecting a concentrated market structure.
Top Reagent Exporters from India — Ranked by Export Value
ADVY CHEMICAL PRIVATE LIMITED is the leading reagent exporter from India, holding a 52.7% share of the $13.1M market across 5,370 shipments from 93 exporters. The top 5 suppliers — ADVY CHEMICAL PRIVATE LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, BEACON DIAGNOSTICS PVT LTD, MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED, BEACON DIAGNOSTICS PRIVATE LIMITED — collectively control 86.7% of total export value, indicating a highly concentrated market. Individual shares are: ADVY CHEMICAL PRIVATE LIMITED (52.7%), ARKRAY HEALTHCARE PRIVATE LIMITED (24.8%), BEACON DIAGNOSTICS PVT LTD (5.2%), MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED (2.3%), BEACON DIAGNOSTICS PRIVATE LIMITED (1.7%).
Top Reagent Exporters from India
Ranked by export value · 93 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ADVY CHEMICAL PRIVATE LIMITED DIAGNOSTIC REAGENTS GOAT ANTI- HUMAN IGGDIAGNOSTIC REAGENTS GOAT ANTI-HUMAN ALBDIAGNOSTIC REAGENTS- GOAT ANTI- HUMAN IGG WHOLE SERUM | $6.9M | 23 | 52.7% |
| 2 | ARKRAY HEALTHCARE PRIVATE LIMITED DIAGNOSTIC KITS -CRYSTAL VC ,PACK SIZE:10 TESTSDIAGNOSTICS KITS -CRYSTAL VCDIAGNOSTIC REAGENTS HUMAN IGG FC AFFINI | $3.3M | 56 | 24.8% |
| 3 | BEACON DIAGNOSTICS PVT LTD DIAGNOSTIC KITS -CRYSTAL VC ,PACK SIZE:10 TESTSDIAGNOSTICS KITS -CRYSTAL VCMEDICAL LABORATORY REAGENTS IOHEXOL SOLU | $679.5K | 32 | 5.2% |
| 4 | MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED DIAGNOSTICS KITS -CRYSTAL VCDIAGNOSTICS USE / DIAGNOSTICS REAGENTS -DIAGNOSTICS USE/LABORATORY REAGENTS-RF LATEX NOS | $295.5K | 17 | 2.3% |
| 5 | BEACON DIAGNOSTICS PRIVATE LIMITED DIAGNOSTIC KITS -CRYSTAL VC ,PACK SIZE:10 TESTSDIAGNOSTICS KITS -CRYSTAL VCMEDICAL LABORATORY REAGENTS IOHEXOL SOLU | $226.5K | 30 | 1.7% |
| 6 | RECKON DIAGNOSTICS PRIVATE LIMITED DIAGNOSTIC KITS -CRYSTAL VC ,PACK SIZE:10 TESTSMEDICAL LABORATORY REAGENTS IOHEXOL SOLUDIAGNOSTIC REAGENTS:WIDAL SLIDE TEST | $146.0K | 1 | 1.1% |
| 7 | BIOLINE DIAGNOSTICS LLP | $138.3K | 10 | 1.1% |
| 8 | ADVANOV PHARMA PRIVATE LIMITED DIAGNOSTIC KITS -CRYSTAL VC ,PACK SIZE:10 TESTSMEDICAL LABORATORY REAGENTS IOHEXOL SOLUDIAGNOSTIC REAGENTS:WIDAL SLIDE TEST | $106.5K | 1 | 0.8% |
| 9 | MEDICLONE BIOTECH PRIVATE LIMITED | $106.4K | 2 | 0.8% |
| 10 | BIONIFY BIOSCIENCE (OPC) PRIVATE LIMITED PHARMACEUTICAL REAGENTS: AFFINITY RESIN[5 LTR X 4 = 20LTR]LABORATORY CHEMICAL/REAGENT: FETAL BOVINE SERUMQFT TUBES FOR DNA QUANTIFICATION REAGENT | $77.6K | 1 | 0.6% |
| 11 | MEDSOURCE OZONE BIO MEDICALS PRIVATE LIMITED DIAGNOSTICS KITS -CRYSTAL VCDIAGNOSTICS USE / DIAGNOSTICS REAGENTS -DIAGNOSTICS USE/LABORATORY REAGENTS-RF LATEX NOS | $72.1K | 11 | 0.5% |
| 12 | SR BIOERA PRIVATE LIMITED PHARMACEUTICAL REAGENTS: AFFINITY RESIN[5 LTR X 4 = 20LTR]LABORATORY CHEMICAL/REAGENT: FETAL BOVINE SERUMDIAGNOSTICS KITS -CRYSTAL VC | $57.1K | 7 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Reagent exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Medsource Ozone Biomedicals Private Limited | Not Listed | Unknown | Unknown | Not verified | Founded in 2003, Medsource Ozone Biomedicals is a leading in vitro diagnostics m |
| Reckon Diagnostics Private Limited | Not Listed | Unknown | Unknown | Not verified | Reckon Diagnostics is listed in the Department of Pharmaceuticals' illustrative |
| Arkray Healthcare Private Limited | Not Listed | Unknown | Unknown | Not verified | Arkray Healthcare is included in the Department of Pharmaceuticals' illustrative |
| Beacon Diagnostics Private Limited | Not Listed | Unknown | Unknown | Not verified | Beacon Diagnostics appears in the Department of Pharmaceuticals' illustrative li |
| Advansource Pharma Private Limited | Not Listed | Unknown | Unknown | Not verified | Advansource Pharma is listed in the Department of Pharmaceuticals' illustrative |
| Bioline Diagnostics LLP | Not Listed | Unknown | Unknown | Not verified | Bioline Diagnostics is included in the Department of Pharmaceuticals' illustrati |
| Mediclon Biotech Private Limited | Not Listed | Unknown | Unknown | Not verified | Mediclon Biotech is listed in the Department of Pharmaceuticals' illustrative li |
| Bionify Bioscience (OPC) Private Limited | Not Listed | Unknown | Unknown | Not verified | Bionify Bioscience is included in the Department of Pharmaceuticals' illustrativ |
TransData Nexus reviewed the regulatory standing of 8 leading Reagent exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Reagent sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often termed India's "Bulk Drug Capital," is a pivotal hub for pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs) and intermediates. The city's Genome Valley hosts numerous R&D centers and biotech firms, fostering innovation in drug development. The ongoing development of Hyderabad Pharma City aims to integrate APIs, formulations, and support services, enhancing the region's capacity for large-scale production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Major companies like Cadila Pharmaceuticals and Zydus Lifesciences are headquartered here, contributing significantly to India's pharmaceutical exports. The region's well-established infrastructure and skilled workforce make it a strategic location for formulation development and manufacturing.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Proximity to major ports facilitates efficient international distribution, while the presence of numerous pharmaceutical companies enhances the region's role in global supply chains. The area's infrastructure supports both bulk drug manufacturing and formulation production, catering to diverse market demands.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical hub, housing over 3,000 factories with an annual turnover of approximately ₹60,000 crore. The region's growth was initially spurred by tax incentives, attracting major companies like Cipla and Dr. Reddy's Laboratories. Despite the phasing out of some tax benefits, the established ecosystem continues to support large-scale pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: While ADVY Chemical Private Limited dominates reagent exports, consider engaging with other top exporters like ARKRAY Healthcare Private Limited and Beacon Diagnostics Pvt Ltd to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad for API sourcing, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics to optimize the supply chain.
- Monitor Regulatory Compliance: Ensure all suppliers adhere to standards set by regulatory bodies such as the CDSCO and WHO to maintain product quality and market access.
- Assess Infrastructure and Logistics: Evaluate the logistical capabilities of each region, considering factors like proximity to ports and transportation networks, to ensure timely and cost-effective distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Reagent exporters from India
Medsource Ozone Biomedicals Pvt. Ltd. — Medsource Ozone Biomedicals secures Series A funding from Xponentia Capital Partners
In August 2024, Medsource Ozone Biomedicals Pvt. Ltd., a leading Indian manufacturer of in vitro diagnostic (IVD) products, raised an undisclosed amount from private equity firm Xponentia Capital Partners. The funds are intended to support the launch of new products, expansion of distribution networks in India and overseas, and the commissioning of a new state-of-the-art manufacturing facility to double production capacity. - IMPACT: The increased production capacity and expanded distribution networks are expected to enhance Medsource Ozone Biomedicals' reagent export capabilities.
Impact: The increased production capacity and expanded distribution networks are expected to enhance Medsource Ozone Biomedicals' reagent export capabilities.
Common Questions — Reagent Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which reagent supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ADVY CHEMICAL PRIVATE LIMITED leads with 2,566 recorded shipments worth $6.9M. ARKRAY HEALTHCARE PRIVATE LIMITED (637 shipments) and BEACON DIAGNOSTICS PVT LTD (569 shipments) are also established high-volume exporters.
Q How many reagent manufacturers are there in India?
India has 93 active reagent exporters with a combined export market of $13.1M across 5,370 shipments to 109 countries. The top 5 suppliers hold 86.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for reagent from India?
Average FOB unit price: $2701.92 per unit, ranging from $0.00 to $98289.84. Average shipment value: $2.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 93 verified Indian exporters of Reagent ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,370 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 109 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,370 Verified Shipments
93 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists